Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Thursday, October 02, 2014 11:04:07 AM
bullish long term investor buy and hold
dollar cost averaging, buy some each month purchase methods, etc...
$VNRX recent news/filings
## source: finance.yahoo.com
Thu, 02 Oct 2014 12:00:00 GMT ~ VolitionRx Announces Prostate Cancer Collaboration with the University of Texas MD Anderson Cancer Center
[PR Newswire] - NAMUR, Belgium, Oct. 2, 2014 /PRNewswire/ --VolitionRx Limited (VNRX), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today announced a study collaboration with The University of Texas MD Anderson Cancer Center's Department of Genitourinary Medical Oncology. The study will examine the competency of VolitionRx NuQ® assays to distinguish anaplastic prostate cancer, a particularly aggressive form of the disease, from typical castration-resistant prostate cancer (CRPC), a less aggressive form. Anaplastic prostate cancers are a clinically defined subset of prostate cancers that behave like small cell prostate carcinomas. Small cell prostate carcinoma is a morphological variant of prostate cancer that is rare at initial diagnosis but often emerges during the castration-resistant progression of the disease and is associated with a distinct, aggressive, clinical behaviour and resistance to standard prostate cancer therapies.
read full: http://finance.yahoo.com/news/volitionrx-announces-prostate-cancer-collaboration-120000365.html
*********************************************************
Thu, 11 Sep 2014 12:00:00 GMT ~ VolitionRx NuQ(R) Blood Test Detects 84% of Colorectal Cancers; Including Both Early- and Later-stage Cancers
[PR Newswire] - NAMUR, Belgium, Sept. 11, 2014 /PRNewswire/ -- VolitionRx Limited (OTCQB: VNRX), a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types, today announced ...
read full: http://finance.yahoo.com/news/volitionrx-nuq-r-blood-test-120000359.html
*********************************************************
Fri, 05 Sep 2014 10:30:00 GMT ~ VolitionRx to Present at the Aegis Capital Corp. 2014 Healthcare & Technology Conference
[PR Newswire] - NAMUR, Belgium, Sept. 5, 2014 /PRNewswire/ -- VolitionRx Limited (VNRX), a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types, today announced that its Chief Executive Officer, Cameron Reynolds, is scheduled to present at the Aegis Capital 2014 Healthcare & Technology Conference, being held September 10-13, 2014 at The Encore at Wynn Hotel in Las Vegas, NV. During his presentation, he will discuss top-line results from analysis of an initial representative 938-subject sample from VolitionRx's 4,800-subject retrospective colorectal cancer blood diagnostic pilot study at Hvidovre Hospital, Denmark. VolitionRx's NuQ® tests utilize the Company's proprietary Nucleosomics® platform, which identifies and measures circulating nucleosome structures for the presence of epigenetic cancer signals within the blood. As part of the Denmark trial, VolitionRx is analyzing samples from approximately 4,800 subjects with colorectal cancer, polyps or adenomas, benign bowel diseases or other malignancies, all of whom have undergone a colonoscopy. Under the trial design, VolitionRx has full access to all Danish national registries and databases.
read full: http://finance.yahoo.com/news/volitionrx-present-aegis-capital-corp-103000329.html
*********************************************************
Wed, 13 Aug 2014 10:30:00 GMT ~ VolitionRx Invests in Laboratory Automation System to Increase Throughput Capacity for Large Clinical Trials
[PR Newswire] - NAMUR, Belgium, Aug. 13, 2014 /PRNewswire/ -- VolitionRx Limited (VNRX), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today announced it has installed a Tecan EVO200 automated liquid handling system in its Namur, Belgium laboratory. The Tecan EVO200 is a robot that will significantly accelerate VolitionRx's large scale clinical studies by increasing the throughput and rate of blood sample analysis by up to five times that of the current manual methods. Initially the robot will be used in a stand-alone mode but Volition is in the process of establishing a Laboratory Information Management System (LIMS) which will integrate the robot into a wider laboratory automation system. This will provide a seamless workflow incorporating blood sample recognition, testing, data capture, and quality control as part of a quality management system.
read full: http://finance.yahoo.com/news/volitionrx-invests-laboratory-automation-system-103000170.html
*********************************************************
Fri, 08 Aug 2014 17:04:24 GMT ~ VOLITIONRX LTD Financials
read full: http://finance.yahoo.com/q/is?s=vnrx
*********************************************************
$VNRX charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$VNRX company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/VNRX/company-info
Ticker: $VNRX
OTC Market Place: OTCQB
CIK code: 0000093314
Company name: VolitionRX Ltd
Company website: http://www.volitionrx.com
Incorporated In: DE, USA
Business Description: VolitionRX is a life sciences company whose goal is to make its non-invasive blood tests for cancer as common and simple to use as existing diabetic and cholesterol tests on similar formats.VolitionRX is managed by a well-respected team with extensive experience in diagnostics and commercialization. Volition's development activities are currently centered in Belgium and will be augmented by commercialization work in Singapore with a focus on bringing its revolutionary diagnostic products to market first in Europe, then the US and worldwide.Less >>
$VNRX share structure
## source: otcmarkets.com
Market Value: $56,700,970 a/o Oct 01, 2014
Shares Outstanding: 13,468,164 a/o Aug 01, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$VNRX extra dd links
Company name: VolitionRX Ltd
Company website: http://www.volitionrx.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/VNRX/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/VNRX/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=VNRX+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=VNRX+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=VNRX+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/VNRX/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/VNRX/news - http://finance.yahoo.com/q/h?s=VNRX+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/VNRX/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/VNRX/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/VNRX/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/VNRX/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/VNRX/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/VNRX/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/VNRX/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/VNRX/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=VNRX+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/VNRX
DTCC (dtcc.com): http://search2.dtcc.com/?q=VolitionRX+Ltd&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=VolitionRX+Ltd
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=VolitionRX+Ltd&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.volitionrx.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.volitionrx.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.volitionrx.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/VNRX/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/VNRX
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/VNRX/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/VNRX/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/VNRX/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000093314&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/VNRX/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/VNRX/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/VNRX/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/VNRX/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=VNRX&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=VNRX
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/VNRX/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=VNRX+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=VNRX+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=VNRX
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=VNRX
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=VNRX+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/VNRX/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=VNRX+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/VNRX.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=VNRX
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/VNRX/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/VNRX/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/VNRX/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/VNRX/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/VNRX
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/VNRX
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/VNRX:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=VNRX
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=VNRX
$VNRX DD Notes ~ http://www.ddnotesmaker.com/VNRX
Recent VNRX News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 08:19:29 PM
- Volition Hosts KOL Roundtable on Sepsis • PR Newswire (US) • 09/11/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 08:06:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 08:05:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 08:05:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 08:04:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 08:04:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 08:04:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 08:03:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 08:03:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 08:02:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 08:02:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 08:02:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 08:02:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 08:01:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 08:01:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2024 12:26:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 08:06:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 08:06:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 08:06:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 08:06:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 08:06:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 08:06:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 08:06:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 08:05:55 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM